We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · April 14, 2020

Nivolumab + Ipilimumab With and Without Local Therapy in Patients With Melanoma Brain Metastases

Journal for immunotherapy of cancer


Additional Info

Disclosure statements are available on the authors' profiles:

Journal for immunotherapy of cancer
Combined Immunotherapy With Nivolumab and Ipilimumab With and Without Local Therapy in Patients With Melanoma Brain Metastasis: A DeCOG* Study in 380 Patients
J Immunother Cancer 2020 Mar 01;8(1)e000333, T Amaral, F Kiecker, S Schaefer, H Stege, K Kaehler, P Terheyden, A Gesierich, R Gutzmer, S Haferkamp, J Uttikal, C Berking, D Rafei-Shamsabadi, L Reinhardt, F Meier, A Karoglan, C Posch, T Gambichler, C Pfoehler, K Thoms, J Tietze, D Debus, R Herbst, S Emmert, C Loquai, JC Hassel, F Meiss, T Tueting, V Heinrich, T Eigentler, C Garbe, L Zimmer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading